Welcome to our dedicated page for Lifeloc Technologies SEC filings (Ticker: LCTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lifeloc Technologies, Inc. (LCTC) SEC filings page on Stock Titan provides structured access to the company’s regulatory disclosures as a fully reporting issuer. Lifeloc files periodic and current reports that describe its business as a U.S.-based manufacturer of evidential breath alcohol testers, related training and supplies, and its development of the SpinDetect/SpinDx centrifugal drug analyzer platform for rapid drug-of-abuse detection.
Through documents such as Form 10-K annual reports and Form 10-Q quarterly reports, investors can review detailed financial statements, including revenue from product sales, royalties and rental income, cost of sales, gross profit and operating expenses for research and development, sales and marketing, and general and administrative activities. These filings also discuss the impact of high research and development spending on operating results as Lifeloc advances its microfluidic “lab-on-a-disk” technology.
Form 8-K current reports offer timely updates on material events. Recent 8-K filings reference the release of quarterly operating results, participation in an investor conference, and an Agreement and Plan of Merger under which a wholly owned subsidiary of Lifeloc will merge with Electronic Systems Technology, Inc., with ELST surviving as a wholly owned subsidiary, subject to customary conditions. These filings provide context on corporate actions, financing arrangements and strategic initiatives that may not be fully captured in periodic reports.
On this page, Stock Titan pairs real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify major themes in Lifeloc’s 10-K and 10-Q filings, understand the significance of 8-K disclosures, and locate information related to capital structure, research and development focus and the SpinDetect/SpinDx program. Filings related to equity issuances, subordinated debentures, credit facilities and merger agreements can also be reviewed here, helping investors analyze how Lifeloc finances and structures its operations.
Lifeloc Technologies is registering 237,432 shares of common stock to issue as stock consideration in its proposed merger with Electronic Systems Technology (ELST). Each ELST share will be converted into the right to receive 0.048 Lifeloc shares, with cash paid instead of fractional shares. After closing, ELST will become a wholly owned subsidiary of Lifeloc and Lifeloc’s existing directors and officers will remain in place.
The merger requires approval by holders of at least 75% of ELST’s 4,946,502 outstanding shares as of December 11, 2025, at a special meeting on February 9, 2026. ELST’s board unanimously recommends voting for the deal, citing ELST’s limited growth prospects and lack of a trading market, while noting related-party ties, the absence of an independent fairness opinion, potential tax uncertainty over reorganization treatment, and available dissenters’ rights under Washington law.
Lifeloc Technologies is registering 237,432 shares of common stock to issue as stock consideration in its planned merger with Electronic Systems Technology (ELST). The Post‑Effective Amendment to the Form S‑4 updates the original registration with new merger disclosures, refreshed financial information, and conforming changes.
Under the Agreement and Plan of Merger, ELST will become a wholly owned subsidiary of Lifeloc, and each ELST share will convert into the right to receive 0.048 Lifeloc shares, with cash paid instead of fractional shares. ELST’s board unanimously approved the deal and recommends shareholders vote in favor, but approval requires at least 75% of ELST’s outstanding common stock. ELST holders have dissenters’ rights under Washington law to seek “fair value” instead of stock.
The filing highlights risks including integration challenges, related‑party conflicts due to overlapping directors and shareholders, the absence of an independent fairness opinion, uncertain U.S. federal tax treatment of the merger, and the lack of typical deal‑protection provisions, which could expose the transaction to delay or competing offers.
Lifeloc Technologies, Inc. (LCTC) furnished a press release announcing operating results for the period ended September 30, 2025. The company made the release available on its website on November 12, 2025 and attached it as Exhibit 99.1.
The information was furnished rather than filed, which means it is not subject to Section 18 liabilities and is not incorporated by reference into other filings unless expressly stated.
Lifeloc Technologies, Inc. reported Q3 2025 results. Total revenues were
For the nine months ended September 30, 2025, revenues were
The company continues investing in SpinDetect™ development. Subsequent to quarter-end, it entered a merger agreement with Electronic Systems Technology, Inc.; an S‑4/A was filed on October 15, 2025, with closing subject to shareholder and regulatory approvals. Common shares outstanding were 2,752,616 as of November 10, 2025.
Lifeloc Technologies (LCTC) announced a merger agreement with Electronic Systems Technology (ELST). A newly formed Lifeloc subsidiary will merge into ELST, and ELST will continue as a wholly owned subsidiary of Lifeloc. ELST shareholders will receive Lifeloc common stock based on an agreed exchange ratio, with cash paid in lieu of fractional shares.
Closing is subject to customary conditions, including ELST shareholder approval, the effectiveness of a Form S-4 registration statement for the shares to be issued, and required regulatory approvals. The agreement includes customary representations, warranties, covenants, termination rights, and conditions.
Lifeloc Technologies, Inc. filed a current report to note that on September 23, 2025 it issued a press release titled “Lifeloc to Present at Emerging Growth Conference on September 25, 2025.” The company is using this filing to formally furnish that press release to the market and to clarify that the release, and any websites linked within it, are not considered “filed” for liability purposes under the Securities Exchange Act or automatically incorporated into other securities filings.
FAQ
What is the current stock price of Lifeloc Technologies (LCTC)?
What is the market cap of Lifeloc Technologies (LCTC)?
